Medical Properties Trust, Inc. (NYSE:MPW) Shares Purchased by Pacific Sun Financial Corp

Share on StockTwits

Pacific Sun Financial Corp boosted its holdings in Medical Properties Trust, Inc. (NYSE:MPW) by 20.4% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 28,570 shares of the real estate investment trust’s stock after acquiring an additional 4,850 shares during the period. Pacific Sun Financial Corp’s holdings in Medical Properties Trust were worth $559,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of MPW. Lenox Wealth Advisors LLC purchased a new position in Medical Properties Trust in the 3rd quarter valued at about $31,000. Cullen Frost Bankers Inc. lifted its holdings in Medical Properties Trust by 70.9% in the 2nd quarter. Cullen Frost Bankers Inc. now owns 1,832 shares of the real estate investment trust’s stock valued at $32,000 after purchasing an additional 760 shares in the last quarter. Manchester Financial Inc. purchased a new position in Medical Properties Trust in the 2nd quarter valued at about $33,000. Cascade Investment Advisors Inc. purchased a new position in Medical Properties Trust in the 2nd quarter valued at about $35,000. Finally, Private Ocean LLC purchased a new position in Medical Properties Trust in the 3rd quarter valued at about $50,000. 71.66% of the stock is currently owned by hedge funds and other institutional investors.

In related news, CFO R Steven Hamner sold 77,500 shares of the firm’s stock in a transaction that occurred on Wednesday, September 25th. The shares were sold at an average price of $19.43, for a total value of $1,505,825.00. Following the transaction, the chief financial officer now owns 1,235,457 shares in the company, valued at $24,004,929.51. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Edward K. Aldag, Jr. sold 101,964 shares of the firm’s stock in a transaction that occurred on Thursday, October 10th. The shares were sold at an average price of $19.78, for a total transaction of $2,016,847.92. Following the completion of the transaction, the chief executive officer now owns 2,058,820 shares in the company, valued at approximately $40,723,459.60. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 279,464 shares of company stock worth $5,359,673. Insiders own 1.18% of the company’s stock.

Shares of MPW stock traded up $0.53 during trading hours on Friday, hitting $19.95. 16,826,344 shares of the company were exchanged, compared to its average volume of 4,039,835. The firm has a market cap of $8.56 billion, a PE ratio of 14.56, a PEG ratio of 3.39 and a beta of 0.52. Medical Properties Trust, Inc. has a 1 year low of $15.25 and a 1 year high of $20.92. The company has a quick ratio of 8.00, a current ratio of 6.27 and a debt-to-equity ratio of 1.02. The firm has a fifty day moving average of $19.84 and a 200 day moving average of $18.53.

Medical Properties Trust (NYSE:MPW) last announced its quarterly earnings data on Thursday, October 31st. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.32 by ($0.12). The company had revenue of $224.70 million for the quarter, compared to analysts’ expectations of $221.40 million. Medical Properties Trust had a return on equity of 6.36% and a net margin of 41.57%. The company’s revenue was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.35 earnings per share. Analysts expect that Medical Properties Trust, Inc. will post 1.32 earnings per share for the current year.

A number of research firms have issued reports on MPW. Berenberg Bank began coverage on shares of Medical Properties Trust in a report on Thursday, September 12th. They issued a “buy” rating and a $22.00 target price on the stock. Zacks Investment Research upgraded shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $22.00 target price on the stock in a report on Wednesday, October 16th. Barclays set a $22.00 target price on shares of Medical Properties Trust and gave the company a “buy” rating in a report on Monday, October 21st. SunTrust Banks upped their target price on shares of Medical Properties Trust from $20.00 to $21.00 and gave the company a “buy” rating in a report on Tuesday, August 27th. Finally, JPMorgan Chase & Co. set a $21.00 target price on shares of Medical Properties Trust and gave the company a “buy” rating in a report on Wednesday, September 4th. One analyst has rated the stock with a sell rating, three have given a hold rating and eight have issued a buy rating to the company. Medical Properties Trust has an average rating of “Buy” and an average target price of $20.18.

About Medical Properties Trust

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

See Also: What is the market perform rating?

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.